FIELD: medicine, neurology. SUBSTANCE: during the stage of exacerbation patients with multiple sclerosis should be intravenously injected by drops with human interleukin-2 (h-IL-2) preparation, for example, roncoleukin, at the dosage of not less than 1 mln IU once per 7d. The method enables to considerably shorten therapy terms in patients with multiple sclerosis at the background of pronounced immune deficiency, decrease the number of relapses and prolong labor capacity period in patients with multiple sclerosis. EFFECT: higher efficiency of therapy. 1 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF THERAPY OF REMITTENT MULTIPLE SCLEROSIS | 2012 |
|
RU2523058C2 |
| METHOD FOR TREATING DISSEMINATED SCLEROSIS | 1991 |
|
RU2016568C1 |
| METHOD FOR TREATING DISSEMINATED SCLEROSIS | 0 |
|
SU1821214A1 |
| METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
| METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN | 2015 |
|
RU2596792C1 |
| METHOD FOR PREDICTION OF STAGE OF MULTIPLE SCLEROSIS TAKING INTO ACCOUNT VALUES OF IMMUNOLOGICAL STATUS | 2013 |
|
RU2528882C1 |
| METHOD FOR PREDICTION OF DEVELOPING MULTIPLE SCLEROSIS TAKING INTO ACCOUNT IMMUNE-METABOLIC VALUES | 2013 |
|
RU2528879C1 |
| TREATMENT OF MULTIPLE SCLEROSIS ACCORDING TO THE METHOD OF KRIVOPALOV-MOSKVIN | 2018 |
|
RU2702120C1 |
| METHOD OF TREATMENT OF LINGERING RELAPSING FORMS OF TUBERCULOSIS AND ITS SPECIFIC COMPLICATIONS IN CHILDREN | 2000 |
|
RU2189249C2 |
| METHOD FOR PRODUCTION OF CELL CULTURE FOR TREATMENT OF VASCULAR DEMYELINATING DISEASES OF NERVOUS SYSTEM AND CELL CULTURE PRODUCED BY THIS METHOD (VERSIONS) | 2007 |
|
RU2347579C1 |
